Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Builders FirstSource Profit Tops Forecasts Despite Weak Housing Market (Benzinga) +++ BUILDERS FIRSTSOURCE Aktie -7,50%

BAXTER Aktie

 >BAXTER Aktienkurs 
16.63 EUR    -13.9%    (Tradegate)
Ask: 16.598 EUR / 200 Stück
Bid: 16.502 EUR / 182 Stück
Tagesumsatz: 20560 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
BAXTER Aktie über LYNX handeln
>BAXTER Performance
1 Woche: -2,7%
1 Monat: +1,7%
3 Monate: -21,8%
6 Monate: -27,1%
1 Jahr: -41,5%
laufendes Jahr: -30,2%
>BAXTER Aktie
Name:  BAXTER INTL DL 1
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US0718131099 / 853815
Symbol/ Ticker:  BTL (Frankfurt) / BAX (NYSE)
Kürzel:  FRA:BTL, ETR:BTL, BTL:GR, NYSE:BAX
Index:  S&P500
Webseite:  http://www.baxter.com/
Profil:  Baxter International Inc. is a leading global heal..
>Volltext..
Marktkapitalisierung:  10214.84 Mio. EUR
Unternehmenswert:  17013.05 Mio. EUR
Umsatz:  9344.82 Mio. EUR
EBITDA:  1372.5 Mio. EUR
Nettogewinn:  -115.02 Mio. EUR
Gewinn je Aktie:  -0.23 EUR
Schulden:  8347.42 Mio. EUR
Liquide Mittel:  1447.17 Mio. EUR
Operativer Cashflow:  656.64 Mio. EUR
Bargeldquote:  0.57
Umsatzwachstum:  -33.99%
Gewinnwachstum:  69.99%
Dividende je Aktie:  0.58 EUR
Dividendenrendite:  2.93%
Dividendenschätzung:  2.93%
Div. Historie:  29.08.25 - 0.14586€
30.05.25 - 0.14586€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  BAXTER, BAXTER INTL, (NYSE:BAX), NYSE:BAX, NYSE BAX
Letzte Datenerhebung:  30.10.25
>BAXTER Kennzahlen
Aktien/ Unternehmen:
Aktien: 513.62 Mio. St.
Frei handelbar: 99.17%
Rückkaufquote: -0.29%
Mitarbeiter: 38000
Umsatz/Mitarb.: 0.24 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 15.9%
Bewertung:
KGV: -
KGV lG: 9.48
KUV: 1.1
KBV: 1.64
PEG-Ratio: -
EV/EBITDA: 12.4
Rentabilität:
Bruttomarge: 35.46%
Gewinnmarge: -2.27%
Operative Marge: 6.62%
Managementeffizenz:
Gesamtkaprendite: -1.04%
Eigenkaprendite: -3.3%
 >BAXTER Anleihen 
Es sind 1 Anleihen zur BAXTER Aktie bekannt.
>BAXTER Peer Group

Es sind 596 Aktien bekannt.
 
30.10.25 - 17:15
BAX Stock Falls Following Q3 Earnings Beat & Sales Miss, ′25 EPS View Down (Zacks)
 
Baxter's Q3 earnings top forecasts, but sales lag and 2025 EPS guidance slips; shares fall despite strength in Pharma and Advanced Surgery....
30.10.25 - 17:15
Here′s What Key Metrics Tell Us About Baxter (BAX) Q3 Earnings (Zacks)
 
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
30.10.25 - 16:33
Baxter signals 2026 dividend reduction and updates full-year 2025 earnings guidance amid operational challenges (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.10.25 - 15:25
Baxter: Gewinn pro Aktie übertrifft Erwartungen, doch Umsatzverfehlung schickt Aktie auf Talfahrt (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
30.10.25 - 15:00
Baxter International (BAX) Beats Q3 Earnings Estimates (Zacks)
 
Baxter (BAX) delivered earnings and revenue surprises of +15.00% and -1.32%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
30.10.25 - 14:39
Baxter tanks after lower FY expectations, Q3 revenue miss (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.10.25 - 13:48
Investors in Baxter International, Inc. Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights - BAX (PR Newswire)
 
NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
30.10.25 - 12:21
Baxter reports mixed Q3 results; initiates Q4 and updates FY outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.10.25 - 12:18
Baxter Reports Third-Quarter 2025 Results (Business Wire)
 
Third-quarter sales from continuing operations of $2.84 billion increased 5% on a reported basis and 2% on an operational basis1,2 Third-quarter U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($0.10); adjusted diluted EPS from continuing operations of $0.69 Andrew Hider joined the company as president and chief executive officer (CEO), now leading the company's focus to drive continuous improvement and sustainable growth and create shareholder value DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2025. “I joined Baxter because it's a global healthcare leader – an iconic brand with an essential portfolio that touches more than 350 million patients every year,” said Andrew Hider, president and CEO. “In my first weeks, I've seen firsthand the passion and expertise that are at the heart of this company. I've been working side-by-side with our teams to understand what d...
30.10.25 - 11:54
Kontoor Brands Appoints Børre Hegbom as Senior Vice President, Global Head of Helly Hansen (Business Wire)
 
GREENSBORO, N.C.--(BUSINESS WIRE)--$KTB--Kontoor Brands, Inc. (NYSE: KTB) today announced the appointment of Børre Hegbom as Senior Vice President, Global Head of Helly Hansen effective immediately. Hegbom will lead the execution of the strategic plan to drive growth across the Helly Hansen business, with responsibility for Sport and Workwear globally. As a member of the Executive Leadership Team, he will report to Scott Baxter, President, Chief Executive Officer and Chairman of the Board of Directors of Kontoor Brands. “Børre's proven track record of driving profitable growth and his deep understanding of what drives consumer demand for the Helly Hansen brand make him the ideal leader for this role," said Scott Baxter, President, Chief Executive Officer and Chairman of the Board of Directors. "His appointment accelerates our ability to execute against the investment roadmap we've developed for Helly Hansen.” Hegbom brings more than two decades of experience with Helly Hansen in roles of...
30.10.25 - 01:12
BAX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire)
 
SAN DIEGO, Oct. 29, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period"), have until December 15, 2025 to seek......
29.10.25 - 15:12
Baxter Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.10.25 - 00:30
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit (PR Newswire)
 
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive......
28.10.25 - 15:45
Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter? (Zacks)
 
Baxter's Q3 results are expected to show steady revenue growth led by Advanced Surgery and Drug Compounding, though IV fluid and anesthesia softness may weigh on EPS....
28.10.25 - 14:42
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to......
28.10.25 - 13:48
Levi & Korsinsky Notifies Shareholders of Baxter International, Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline (PR Newswire)
 
NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Baxter......
28.10.25 - 13:03
Baxter Planning Named a Leader in IDC MarketScape for AI-Enabled Service Parts Management (PR Newswire)
 
AUSTIN, Texas, Oct. 28, 2025 /PRNewswire/ -- Baxter Planning, a leading provider of Service Supply Chain (SSC) solutions, today announced it has been named a Leader in the IDC MarketScape: Worldwide AI-Enabled Service Parts Management (SPM) 2025 Vendor Assessment (doc # US52967925,......
28.10.25 - 09:33
ViCentra Strengthens Leadership Team to Accelerate Growth (PR Newswire)
 
Karen Baxter , former VP & GM at Dexcom with deep expertise in diabetes device commercialization across Europe, joins as SVP Sales , Europe Jay Little, leader from Medtronic Diabetes, appointed VP Strategy & Business Development Team expansion will drive growth strategy, market......
27.10.25 - 13:48
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit - BAX (PR Newswire)
 
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
27.10.25 - 08:45
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm (PR Newswire)
 
LOS ANGELES, Oct. 27, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. ("Baxter" or "the Company") (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Gelobte glaubt an die Kompetenz der Jury. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!